177Lu-DOTATATE 肽受体放射性核素治疗中的胆囊显影:肝转移灶的潜在模拟者
治疗后SPECT/CT(而非治疗前或治疗后PET/CT)显示胆囊显影,提示镥-177-DOTATATE经胆汁排泄。该病例提示胆汁排泄的镥-177-DOTATATE可成为肝转移灶的罕见模拟者,SPECT/CT对精确解剖定位、避免误判具有重要作用。
要点
- 镥-177-DOTATATE治疗后SPECT/CT可见胆囊显影,提示药物经胆汁排泄。
- 该胆囊显影仅在治疗后SPECT/CT出现,治疗前及治疗后PET/CT均未见。
- 胆汁排泄的镥-177-DOTATATE可模拟肝转移灶,需SPECT/CT精确解剖定位以避免误判。
核心结论
- 胆汁排泄的镥-177-DOTATATE可能成为肝转移灶的罕见模拟者。
- SPECT/CT对精确解剖定位、避免误判具有重要作用。
研究设计与样本
- 本文为病例报告,对象为一名30岁男性假肌源性血管内皮瘤患者。
主要发现
- 治疗后SPECT/CT显示胆囊显影,而治疗前及治疗后PET/CT均未见胆囊显影。
- 治疗后SPECT/CT的胆囊显影证实镥-177-DOTATATE排泄进入胆汁。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Gallbladder visualization represents a rare incidental finding when using somatostatin receptor-targeted SPECT radiopharmaceuticals such as In-octreotide. We present the case of a 30-year-old man with pseudomyogenic hemangioendothelioma who underwent Ga-DOTATATE PET/CT for restaging of metastatic disease and subsequent treatment with peptide receptor radionuclide therapy with Lu-DOTATATE. Posttherapeutic SPECT/CT, but not pretherapeutic or posttherapeutic PET/CT, showed gallbladder visualization, evidencing Lu-DOTATATE excretion into the bile. This case highlights that biliary Lu-DOTATATE excretion may represent a rare mimicker of hepatic metastases and emphasizes the role SPECT/CT for precise anatomical correlation to avoid misinterpretation.
引用
- Diekmann J, Werner RA, Ross TL, et al. Gallbladder Visualization in Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE: A Potential Mimicker of Hepatic Metastases. Clin Nucl Med. 2020. PMID: 32657878. doi:10.1097/RLU.0000000000003192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。